financetom
Business
financetom
/
Business
/
ATI Insider Sold Shares Worth $1,540,250, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ATI Insider Sold Shares Worth $1,540,250, According to a Recent SEC Filing
Sep 21, 2024 9:12 PM

03:26 AM EDT, 09/18/2024 (MT Newswires) -- Robert S Wetherbee, Director, Executive Chairman, on September 16, 2024, sold 25,000 shares in ATI (ATI) for $1,540,250. Following the Form 4 filing with the SEC, Wetherbee has control over a total of 511,443 shares of the company, with 511,443 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1018963/000095017024107517/xslF345X05/ownership.xml

Price: 60.64, Change: -1.20, Percent Change: -1.94

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stellantis CEO calls for softer EU emissions rules as he announces new hiring in Italy
Stellantis CEO calls for softer EU emissions rules as he announces new hiring in Italy
Oct 20, 2025
MILAN, Oct 20 (Reuters) - Stellantis ( STLA ) CEO announced on Monday 400 new hires in Italy and confirmed plans to ramp up output in the country while warning that European Union rules to cut carbon emissions need to be changed to support car production in the region. Antonio Filosa, who met Italian unions in Turin in one of...
Verastem Says Median Overall Survival Not Reached in Partner's Phase 1/2 Pancreatic Cancer Study; Shares Fall
Verastem Says Median Overall Survival Not Reached in Partner's Phase 1/2 Pancreatic Cancer Study; Shares Fall
Oct 20, 2025
12:53 PM EDT, 10/20/2025 (MT Newswires) -- Verastem ( VSTM ) said Sunday that results from partner GenFleet Therapeutics' phase 1/2 study in China of GFH375 in patients with KRAS G12D mutant advanced pancreatic ductal adenocarcinoma did not meet the median overall survival at data cutoff. Among 59 heavily pre-treated patients, 40.7% achieved overall response rate at the 600 milligram...
Kenvue urges US FDA to reject request for Tylenol's autism warning
Kenvue urges US FDA to reject request for Tylenol's autism warning
Oct 20, 2025
Oct 20 (Reuters) - Kenvue ( KVUE ) has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain medication Tylenol for use during pregnancy, after President Donald Trump linked the drug to the condition. A citizen petition filed last month requested changes to the labeling of the drug for use during pregnancy that...
Churchill Resources Provides Fall Exploration Program Update For Its Black Raven Property
Churchill Resources Provides Fall Exploration Program Update For Its Black Raven Property
Oct 20, 2025
12:54 PM EDT, 10/20/2025 (MT Newswires) -- Churchill Resources ( CRICF ) on Monday offered an update on its fall exploration program at the Black Raven Property in Newfoundland, which includes the historic Frost Cove Antimony and Stewart Gold mines. The company mobilized a second drill rig on October 14 and by October 18 had completed 16 core holes totaling...
Copyright 2023-2026 - www.financetom.com All Rights Reserved